Liposomes and viruses for gene therapy of cystic fibrosis

Journal of Aerosol Medicine: Deposition, Clearance, and Effects in the Lung

Volumn 9, Issue 1, 1996, Pages 79-88

  Coutelle, Charles ^a   Williamson, Robert ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

Author keywords

adenovirus; cystic fibrosis; gene therapy; liposomes

Indexed keywords

DNA; LIPOSOME; TRANSMEMBRANE CONDUCTANCE REGULATOR; VIRUS VECTOR;

AEROSOL; CLINICAL TRIAL; CYSTIC FIBROSIS; DOSE RESPONSE; GENE EXPRESSION; GENE THERAPY; HUMAN; HUMAN CELL; HUMAN TISSUE; ION TRANSPORT; PHARMACOKINETICS; PHASE 1 CLINICAL TRIAL; REVIEW; VIRUS REPLICATION;

EID: 0029926625     PISSN: 08942684     EISSN: None     Source Type: Journal    
DOI: 10.1089/jam.1996.9.79     Document Type: Review

References (44)

1. ALTON, E.W.F.W., HAY, J.G., MUNRO, C., and GEDDES, D.M. (1987). Measurement of nasal potential difference in adult cystic fibrosis. Young's syndrome, and bronchiectasis. Thorax 42:815-817.
2. ALTON, E.W.F.W., MIDDLETON, P.G., CAPLEN, N.J., SMITH, S.N., STEEL, D.M., MUNGONKE, F.M., JEFFREY, P.K., GEDDES, D.M., HART, S.L., WILLIAMSON, R., FASOLD, K.I., MILLER, A.D., DICKINSON, P., STEVENSON, B.J., MCLACHLAN, G., DORIN, J.R., PORTEUS, D.J. (1993). Non-invasive liposome-mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice. Nature Genet. 5:135-142.
3. BEAR, C.E., LI, C., KARTNER, N., BRIDGES, R.J., JENSEN, T.J., RAMJEESINGH, M., and RIORDAN, J.R. (1992). Purification and functional reconstitution of the cystic fibrosis transmembrane regulator (CFTR). Cell 68:809-818.
4. BOUCHER, R.C., KNOWLES, M.R., CANTLEY, L., and GATZY, J.T. (1986). Na transport in cystic fibrosis respiratory epitheha. J. Clin. Invest. 78:1245-1252.
5. BOUCHER, R.C., KNOWLES, M.R., JOHNSON, L.G., OLSON, J.C., PICKLES, R., WILSON, J.M., ENGELHARDT, J.F., YANG, Y., and GROSSMAN, M. (1994). Clinical protocol; Gene Therapy for cystic fibrosis using E1-deleted adenovirus: A phase I trial in the nasal cavity. Hum. Gene Ther. 5:615-639.
6. CAPLEN, N.J., GAO, X., HAYES, P., ELAESWARAPU, R., FISHER, G., KINRADE, E., CHAKERA, A., SCHORR, J., HUGHES, B., DORIN, J.R., PORTEOUS, D.J., ALTON, E.W.F.W.K., GEDDES, D.M., HODSON, I.E., COUTELLE, C., WILLIAMSON, R., HUANG, L., and GILCHRIST, C. (1994). Gene therapy for cystic fibrosis in human subjects by liposome mediated DNA transfer: Regulatory process and production of resources. Gene Ther. 1:139-147.
7. CAPLEN, N.J., ALTON, E.W.F.W.K., MIDDELTON, P.G., DORIN, J.R., STEVENSON, B.J., GAO, X., DURHAM, S., JEFFREY, P.K., HODSON, M.E., COUTELLE, C., HUANG, L., PORTEOUS, D.J., WILLIAMSON, R., ALTON, E.W.F.W., and GEDDES, D.M. (1995). Liposome mediated CFTR gene transfer to the nasal epithelia of patients with cystic fibrosis. Nature Med. 1:39-46.
8. CLOTHIER, C.M. (1992). Report of the Committee on the Ethics of Gene Therapy (No. Cm 1788), HMSO.
9. CRYSTAL, R.G., MCELVANEY, N.G., ROSENFELD, M.A., CHU, C.-S., MASTRANGELI, A., HAY, J.G., BRODY, S.L., JAFFE, H.A., EISSA, N.T., and DANEL, C. (1994). Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nature Genet. 8:42-51.
10. DRUMM, M.L., WILKINSON, D.J., SMIT, L.S., WORRELL, R.T., STRONG, T.V., FRIZZELL, R.A., DAWSON, D.C., and COLLINS, F.S. (1991). Chloride conductance expressed by ΔF508 and other mutant CFTRs in Xenopus oocytes. Science 254:1797-1799.
11. FELGNER, J.H., KUMAR, R., SRIDHAR, C.N., WHEELER, C.J., TSAI, Y.J., BORDER, R., RAMSEY, P., MARTIN, M., and FELGNER, P.L. (1994). Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J. Biol. Chem. 269:2550-2561.
12. FELGNER, P.L., GADEK, T.R., HOLM, M., ROMAN, R., CHAN, H.W., WENZ, M., NORTHROP, J.P., RINGOLD, G.M., and DANIELSEN, M. (1987). Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. U.S.A. 84:7413-7417.
13. GAO, X., and HUANG, L. (1991). A novel cationic liposome for efficient transfection of mammalian cells. Biochem. Biophys. Res. Commun. 179:280-285.
14. GERSHON, H., GHIRLANDO, R., GUTTMAN, S.B., and MINSKY, A. (1993). Mode of formation and structural features of DNA-cationic liposome complexes used for transfection. Biochemistry 32:7143-7151.
15. GILULA, N.B., REEVES, O.R., and STEINBACH, A. (1972). Metabolic coupling, ionic coupling and cell contacts. Nature (London) 235:262-265.
16. GRAHAM, F.L., SMILEY, J., RUSSEL, W.C., and NAIM, D. (1977). Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36:59-72.
17. GREGORY, R.J., CHENG, S.H., RICH, D.P., MARSHALL, J., PAUL, S., HEHIR, K., OSTEDGAARD, L., KLINGER, K.W., WELSH, M.J., and SMITH, A.E. (1990). Expression and characterization of the cystic fibrosis transmembrane conductance regulator. Nature (London) 347:382-386.
18. HOROWITZ, M.S. (1990). Adenoviruses. In B.N. Fields, and D.M. Knipe, eds. Virology. Raven Press, New York, 1723-1740.
19. HYDE, S.C., GILL, D.R., HIGGINS, C.F., TREZISE, A.E.O., MACVINISH, L.J., CUTHBERT, A.W., RATCLIFF, R., EVANS, M.J., and COLLEDGE, W.H. (1993). Correction of the ion transport defect in cystic fibrosis transgenic mice by gene therapy. Nature (London) 362:250-255.
20. JOHNSON, L.G., OLSEN, J.C., SARKADI, B., MOORE, K.L., SWANSTROM, R., and BOUCHER, R.C. (1992). Efficiency of gene transfer for restoration of normal airway epithelial function in cystic fibrosis. Nature Genet. 2:21-25.
21. KNOWLES et al. (1995). A controlled study of adenoviral vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis. N. Engl. J. Med. 333:823-831.
22. LAMB, B.T., SISODA, S.S., LAWLER, A.M., SLUNT, H.H., KITT, C.A., KEARNES, W.G., PEARSON, P.L., PRICE, D.L., and GEARHART, J.D. (1993). Introduction and expression of the 400 kilobase precursor amyloid protein gene in transgenic mice. Nature Genet. 5:22-29.
23. MASTRANGELI, A., DANEL, C., ROSENFELD, M.A., STRATFORD-PERRICAUDET, L., PERICAUDET, M., PAVIRANI, A., LECOCQ, J.-P., and CRYSTAL, R.G. (1993). Diversity of airway epithelial cell targets for in vivo recombinant adenovirus-mediated transfer. J. Clin. Invest. 91:225-234.
24. MCELVANEY, N.G., and CRYSTAL, R.G. (1995). IL-6 release and airway administration of human CFTR cDNA adenovirus vector. Nature Med. 1:182-184.
25. MILLER, A.D. (1992). Human gene therapy comes of age. Nature (London) 357:455-460.
26. NABEL, E.G., GORDON, D., YANG, Z.-Y., LING, X., SAN, H., PLAUTZ, G.E., WU, B.-Y., GAO, X., HUANG, L., and NABEL, G.J. (1992a). Gene transfer in vivo with DNA-liposome complexes: Lack of autoimmunity and gonadal localization. Hum. Gene Ther. 3:649-656.
27. NABEL, G.J., CHANG, A., NABEL, E.G., PLAUTZ, G., FOX, B.A., HUANG, L., and SHU, S. (1992b). Clinical protocol: Immunotherapy of malignancy by in vivo gene transfer into tumors. Hum. Gene Ther. 3:399-410.
28. NABEL, G.J., NABEL, E.G., YANG, Z., FOX, B.A., PLAUTZ, G., GAO, X., HUANG, L., SHU, S., GORDON, D., and CHANG, A.E. (1993). Direct gene transfer with DNA-liposome complexes in melanoma: Expression, biological activity and lack of toxicity in humans. Proc. Natl. Acad. Sci. U.S.A. 90:11307-11311.
29. RICH, D.P., ANDERSON, M.P., GREGORY, R.J., CHENG, S.H., PAUL, S., JEFFERSON, D.M., MCCANN, J.D., KLINGER, K.W., SMITH, A.E., and WELSH, M.J. (1990). Expression of cystic fibrosis transmembrane conductance regulator corrects defective chloride channel regulation in cystic fibrosis airway epithelial cells. Nature (London) 347:358-363.
30. 1-antitrypsin gene to the lung epithelium in vivo. Science 252:431-434.
31. ROSENFELD, M.A., YOSHIMURA, K., TRAPNELL, B.C., YONEYAMA, K., ROSENTHAL, E.R., DALEMANS, W., FUKAYAMA, M., BARGON, J., STIER, L.E., STRATFORD-PERRICAUDET, PERRICAUDET, M., GUGGINO, W.B., PAVIRANI, A., LECOCQ, J.-P., and CRYSTAL, R.G. (1992). In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 68:143-155.
32. STERNBERG, B., SORGI, F.L., and HUANG, L. (1994). New structures in complex formation between DNA and cationic liposomes visualized by freeze-fracture electron microscopy. FEBS Lett. 356:361-366.
33. STEWART, M.J., PLAUTZ, G.E., DEL BOUNO, L., YANG, Z.Y., XU, L., GAO, X., HUANG, L., NABEL, E.G., and NABEL, G.J. (1992). Gene transfer in vivo with DNA-liposome complexes: Safety and acute toxicity in mice. Human. Gene Ther. 3(3):267-276.
34. STRAUSS, S. (1984). Adenovirus infections in humans. In H.S. Ginsberg, ed. Adenoviruses. Plenum Press, New York, 451-496.
35. STRIBLING, R., BRUNETTE, E., LIGGITT, D., GAENSLER, K., and DEBS, R. (1992). Aerosol gene delivery in vivo. Proc. Natl. Acad. Sci. U.S.A. 89:11277-11281.
36. TRAPNELL, B.C., CHU, C.-S., PAAKKO, P.K., BANKS, T.C., YOSHIMURA, K., FERRANS, V.J., CHERNICK, M.S., and CRYSTAL, R.G. (1991). Expression of the cystic fibrosis transmembrane regulator gene in the respiratory tract of normal individuals and individuals with cystic fibrosis. Proc. Natl. Acad. Sci. U.S.A. 88:6565-6569.
37. WELSH, M.J., SMITH, A.S., ZABNER, J., RICH, D.P., SCOTT, M.G., GREGORY, R.J., PRATT, B.M., and MOSCICKI, R.A. (1994). Clinical protocol: Cystic fibrosis gene therapy using an adenovirus vector: In vivo safety and efficacy in nasal epithelium. Hum. Gene Ther. 5:209-219.
38. WHITSETT, J.A., DEY, C.R., STRIPP, B.R., WIKENHEISER, K.A., CLARK, J.C., WERT, S.E., GREGORY, R.J., SMITH, A.E., COHN, J.A., WILSON, J.M., and ENGELHARDT, J.F. (1992). Human cystic fibrosis transmembrane conductance regulator directed to respiratory epithelial cells of transgenic mice. Nature Genet. 2:13-20.
39. WILMOTT, R.W., WHITSETT, J.A., and TRAPNELL, B. (1994). Gene therapy for cystic fibrosis utilizing a replication deficient recombinant adenovirus vector to deliver the human cystic fibrosis transmembrane conductance regulator cDNA to the airways. A phase I study. Hum. Gene Ther. 5:1019-1057.
40. WILSON, J.M., ENGELHARDT, J.F., GROSSMAN, M., SIMON, R.H., and YANG, Y. (1994). Clinical protocol: Gene therapy of cystic fibrosis lung disease using E1 deleted adenoviruses: A phase I trial. Hum. Gene Ther. 5:501-519.
41. YANG, Y., RAPER, S.E., COHN, J.A., ENGELHARDT, J.F., and WILSON, J.M. (1993). An approach for treating the hepatobilliar disease of cystic fibrosis by somatic gene transfer. Proc. Natl. Acad. Sci. U.S.A. 90:4601-4605.
42. YOSHIMURA, K., ROSENFELD, M.A., NAKAMURA, H., SCHERER, E.M., PAVIRANI, A., LECOCQ, J.-P., and CRYSTAL, R.G. (1992). Expression of the human cystic fibrosis transmembrane conductance regulator gene in the mouse lung after in vivo intratracheal plasmid-mediated gene transfer. Nucleic Acids Res. 20:3233-3240.
43. ZABNER, J., COUTURE, L.A., GREGORY, R.J., GRAHAM, S.M., SMITH, A.E., and WELSH, M.J. (1993). Adenovirus-mediated gene transfer transiently corrects the transport defect in nasal epithelia of patients with cystic fibrosis. Cell 75:207-216.
44. ZABNER, J., PETERSEN, D.M., PUGA, A.P., GRAHAM, S.M., COUTURE, L.A., KEYES, L.D., LUKASON, M.J., ST. GEORGE, J.A., GREGORY, R.J., SMITH, A.E., and WELSH, M.J. (1994). Safety and efficacy of repetitive adenovirus-mediated transfer of CFTR cDNA to airway epithelia of primates and cotton rats. Nature Genet. 6:75-83.